FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2099682824> ?p ?o ?g. }

• W2099682824 endingPage "1451" @default.
• W2099682824 startingPage "1451" @default.
• W2099682824 abstract "To evaluate the efficiency of a combination of trimethoprim and sulfamethoxazole in patients with spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD).Placebo-controlled, double-blind crossover trial in 22 patients with genetically confirmed SCA3/MJD. Study phases of 6 months were separated by a washout period of 4 weeks. Dosages were a combination of trimethoprim, 160 mg, and sulfamethoxazole, 800 mg, twice daily for 2 weeks, followed by a combination of trimethoprim, 80 mg, and sulfamethoxazole, 400 mg, twice daily for 5.5 months.Outpatient department of the Neurological Clinic, Ruhr-University, Bochum, Germany.Ataxia ranking scale, self-assessment score, static posturography, and results of motor performance testing. Effects on the visual system were studied using the achromatic Vision Contrast Test System and the Farnsworth-Munsell 100-hue test for color discrimination. Physical and mental health were documented using the Medical Outcomes Study 36-Item Short-Form Health Survey. Subgroup analyses assessed the influence of age, sex, age at onset, duration of the disease, phenotype, and CAG repeat length on test performance.Twenty of 22 patients completed the study. Dropouts were due to a rash (placebo phase) and an attempted suicide in a family conflict. Trimethoprim-sulfamethoxazole therapy had no significant effect in SCA3/MJD patients in the short-term analysis (2 weeks) or in the long-term interval (6 months).In contrast to previous reports that studied smaller groups of patients, treatment with trimethoprim-sulfamethoxazole did not improve the diverse and complex movement disorders caused by SCA3/MJD. Trimethoprim-sulfamethoxazole had no effect on the visual system and cannot be recommended as a continuous treatment for SCA3/MJD patients." @default.
• W2099682824 created "2016-06-24" @default.
• W2099682824 creator A5027450597 @default.
• W2099682824 creator A5033072595 @default.
• W2099682824 creator A5036808789 @default.
• W2099682824 creator A5044775207 @default.
• W2099682824 creator A5065989485 @default.
• W2099682824 creator A5074432637 @default.
• W2099682824 creator A5076004371 @default.
• W2099682824 creator A5090739298 @default.
• W2099682824 date "2001-09-01" @default.
• W2099682824 modified "2023-10-16" @default.
• W2099682824 title "Double-blind Crossover Trial of Trimethoprim-Sulfamethoxazole in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease" @default.
• W2099682824 cites W1531178007 @default.
• W2099682824 cites W153284124 @default.
• W2099682824 cites W1968505667 @default.
• W2099682824 cites W2003757122 @default.
• W2099682824 cites W2009918146 @default.
• W2099682824 cites W2015419243 @default.
• W2099682824 cites W2017368342 @default.
• W2099682824 cites W2021057019 @default.
• W2099682824 cites W2037377025 @default.
• W2099682824 cites W2038610378 @default.
• W2099682824 cites W2042811939 @default.
• W2099682824 cites W2053009171 @default.
• W2099682824 cites W2057322261 @default.
• W2099682824 cites W2058511920 @default.
• W2099682824 cites W2073012734 @default.
• W2099682824 cites W2086858480 @default.
• W2099682824 cites W2110008395 @default.
• W2099682824 cites W2117549410 @default.
• W2099682824 cites W2123292231 @default.
• W2099682824 cites W2135124405 @default.
• W2099682824 cites W2160720083 @default.
• W2099682824 cites W2411829043 @default.
• W2099682824 cites W2434047125 @default.
• W2099682824 cites W2467529392 @default.
• W2099682824 doi "https://doi.org/10.1001/archneur.58.9.1451" @default.
• W2099682824 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11559318" @default.
• W2099682824 hasPublicationYear "2001" @default.
• W2099682824 type Work @default.
• W2099682824 sameAs 2099682824 @default.
• W2099682824 citedByCount "38" @default.
• W2099682824 countsByYear W20996828242012 @default.
• W2099682824 countsByYear W20996828242013 @default.
• W2099682824 countsByYear W20996828242015 @default.
• W2099682824 countsByYear W20996828242016 @default.
• W2099682824 countsByYear W20996828242018 @default.
• W2099682824 countsByYear W20996828242019 @default.
• W2099682824 countsByYear W20996828242020 @default.
• W2099682824 countsByYear W20996828242021 @default.
• W2099682824 countsByYear W20996828242022 @default.
• W2099682824 countsByYear W20996828242023 @default.
• W2099682824 crossrefType "journal-article" @default.
• W2099682824 hasAuthorship W2099682824A5027450597 @default.
• W2099682824 hasAuthorship W2099682824A5033072595 @default.
• W2099682824 hasAuthorship W2099682824A5036808789 @default.
• W2099682824 hasAuthorship W2099682824A5044775207 @default.
• W2099682824 hasAuthorship W2099682824A5065989485 @default.
• W2099682824 hasAuthorship W2099682824A5074432637 @default.
• W2099682824 hasAuthorship W2099682824A5076004371 @default.
• W2099682824 hasAuthorship W2099682824A5090739298 @default.
• W2099682824 hasConcept C126322002 @default.
• W2099682824 hasConcept C141071460 @default.
• W2099682824 hasConcept C142724271 @default.
• W2099682824 hasConcept C1862650 @default.
• W2099682824 hasConcept C187212893 @default.
• W2099682824 hasConcept C204787440 @default.
• W2099682824 hasConcept C27081682 @default.
• W2099682824 hasConcept C2777748165 @default.
• W2099682824 hasConcept C2779134260 @default.
• W2099682824 hasConcept C2779425571 @default.
• W2099682824 hasConcept C2779500118 @default.
• W2099682824 hasConcept C2780728791 @default.
• W2099682824 hasConcept C501593827 @default.
• W2099682824 hasConcept C54355233 @default.
• W2099682824 hasConcept C71924100 @default.
• W2099682824 hasConcept C86803240 @default.
• W2099682824 hasConcept C87813604 @default.
• W2099682824 hasConceptScore W2099682824C126322002 @default.
• W2099682824 hasConceptScore W2099682824C141071460 @default.
• W2099682824 hasConceptScore W2099682824C142724271 @default.
• W2099682824 hasConceptScore W2099682824C1862650 @default.
• W2099682824 hasConceptScore W2099682824C187212893 @default.
• W2099682824 hasConceptScore W2099682824C204787440 @default.
• W2099682824 hasConceptScore W2099682824C27081682 @default.
• W2099682824 hasConceptScore W2099682824C2777748165 @default.
• W2099682824 hasConceptScore W2099682824C2779134260 @default.
• W2099682824 hasConceptScore W2099682824C2779425571 @default.
• W2099682824 hasConceptScore W2099682824C2779500118 @default.
• W2099682824 hasConceptScore W2099682824C2780728791 @default.
• W2099682824 hasConceptScore W2099682824C501593827 @default.
• W2099682824 hasConceptScore W2099682824C54355233 @default.
• W2099682824 hasConceptScore W2099682824C71924100 @default.
• W2099682824 hasConceptScore W2099682824C86803240 @default.
• W2099682824 hasConceptScore W2099682824C87813604 @default.
• W2099682824 hasIssue "9" @default.
• W2099682824 hasLocation W20996828241 @default.

• next